Brain atrophy in healthy aging is related to CSF levels of Aβ1-42. - Wikidata - wikimedia - TriplyDB

Brain atrophy in healthy aging is related to CSF levels of Aβ1-42.

Brain atrophy in healthy aging is related to CSF levels of Aβ1-42.

http://www.wikidata.org/entity/Q34514638

about

Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease Are Anxiety Disorders Associated with Accelerated Aging? A Focus on Neuroprogression The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception CSF T-Tau/Aβ42 predicts white matter microstructure in healthy adults at risk for Alzheimer's disease The Alzheimer's disease neuroimaging initiative: progress report and future plans Cognitive decline and brain pathology in aging--need for a dimensional, lifespan and systems vulnerability view.2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception.Magnetic resonance imaging in Alzheimer's Disease Neuroimaging Initiative 2 Update on the magnetic resonance imaging core of the Alzheimer's disease neuroimaging initiative.Association of gray matter atrophy with age, β-amyloid, and cognition in aging Quantitative structural MRI for early detection of Alzheimer's disease.White matter integrity is associated with cerebrospinal fluid markers of Alzheimer's disease in normal adults.New tools for the study of Alzheimer's disease: what are biomarkers and morphometric markers teaching us?The effects of aging and Alzheimer's disease on cerebral cortical anatomy: specificity and differential relationships with cognition Structural imaging in early pre-states of dementia.Relations between brain tissue loss, CSF biomarkers, and the ApoE genetic profile: a longitudinal MRI study.Longitudinal MRI atrophy biomarkers: relationship to conversion in the ADNI cohort Relationship between CSF biomarkers of Alzheimer's disease and rates of regional cortical thinning in ADNI data.The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception.Role of structural MRI in Alzheimer's disease The aging hippocampus: interactions between exercise, depression, and BDNF Should we disclose amyloid imaging results to cognitively normal individuals?Enrichment and stratification for predementia Alzheimer disease clinical trials.Stroke risk interacts with Alzheimer's disease biomarkers on brain aging outcomes.Cortical gray matter atrophy in healthy aging cannot be explained by undetected incipient cognitive disorders: a comment on Burgmans et al. (2009).Nonlinear registration of longitudinal images and measurement of change in regions of interest Amyloid-β associated cortical thinning in clinically normal elderly.Biomarkers predicting Alzheimer's disease in cognitively normal aging.Brain amyloid-β burden is associated with disruption of intrinsic functional connectivity within the medial temporal lobe in cognitively normal elderly Temporal evolution of biomarkers and cognitive markers in the asymptomatic, MCI, and dementia stage of Alzheimer's disease What is normal in normal aging? Effects of aging, amyloid and Alzheimer's disease on the cerebral cortex and the hippocampus Spatially distinct atrophy is linked to β-amyloid and tau in preclinical Alzheimer disease Emerging β-amyloid pathology and accelerated cortical atrophy.Hippocampal hyperactivation associated with cortical thinning in Alzheimer's disease signature regions in non-demented elderly adults.Cerebrospinal fluid proteins predict longitudinal hippocampal degeneration in early-stage dementia of the Alzheimer type Fluid biomarkers in Alzheimer disease.Usefulness of DNA Methylation Levels in COASY and SPINT1 Gene Promoter Regions as Biomarkers in Diagnosis of Alzheimer's Disease and Amnestic Mild Cognitive Impairment CSF biomarker and PIB-PET-derived beta-amyloid signature predicts metabolic, gray matter, and cognitive changes in nondemented subjects.Cerebrospinal Fluid Markers of Alzheimer's Disease Pathology and Microglial Activation are Associated with Altered White Matter Microstructure in Asymptomatic Adults at Risk for Alzheimer's Disease.Biomarkers for the clinical evaluation of the cognitively impaired elderly: amyloid is not enough.

P2860

Q24595802-DBC30D48-CCAD-4907-915C-8E7DAF5FA90A Q26765559-9C6C7E53-12D0-4393-9A04-6FFD61C3805F Q27006831-21C643AB-40C6-46C0-8E7B-6D79F356FE97 Q28728773-5F04DD74-7D4A-45A5-96CA-B833F48AC2A1 Q28749585-204D62A5-E0D2-43FC-A2A6-DEC82BD30868 Q30800136-449BF17C-9536-4B6D-8DE0-1826D61B6F7A Q30971403-31DE1C0A-1589-47C7-9890-86FFC46CA050 Q30981669-E4474A79-2EAA-4F7A-8005-340C0DAFF58E Q33572446-72F51AFC-C876-4819-A37A-44A8BE2DFC4C Q33582714-A766E361-9C2F-43E2-B6C9-52A356090B98 Q33729033-342D26A7-1891-4817-B63C-A4AD430DDFFB Q33864697-6A4A0F8E-C135-4295-A80B-FC3E9C968D25 Q33881726-1A6306FC-4CDA-4992-8B94-0A6ECB39A37B Q33902744-4A74FF1E-B8A6-46B8-9DD3-7A0D636202A3 Q33967561-6A23838F-62C3-41FD-9DB8-12BBA82B0B8B Q33987747-0B16B8C5-C590-4EB8-B646-0CB6441DE6DF Q33996059-B37E1952-3A31-4838-9D0F-D13D8A14D745 Q34039952-EB9BF933-DC85-417B-9A73-1FD7637AA54B Q34065449-1882FE29-41CF-4934-8B01-C48FEE5CB9B0 Q34173192-C90E8123-C796-411C-A62E-A26E374D3024 Q34181430-21529300-B142-4BCF-AE7A-137121E4059C Q34286140-B9E0978F-2556-48AD-847E-C96D92159026 Q34452239-753313B0-B579-4515-B02C-A75B8E7F6411 Q34482685-7385ADD6-85C9-44F2-9D3A-2A723D2DFE27 Q34746717-EBB77B5C-3982-4714-B97B-3290EE295D91 Q35046222-5EB4AA68-5DCC-4419-81EB-DEEE14A2D9CF Q35053524-572CB347-835C-4456-80A1-FBE2AFB3C1A6 Q35091673-32F6EC02-7BAB-49C2-B6ED-9843C3AED412 Q35092722-BF9DC702-DEC5-4A1B-97C6-9AF2ABA48CA6 Q35106997-323C0959-12E4-407A-8B36-8C12CFD50210 Q35129501-8D94860B-CCBC-4F23-9339-792C5343C87C Q35195654-2EAC00D2-2107-4641-950E-DF9F0604857A Q35542164-190191BE-2873-4DAB-89C6-1790A82E5E16 Q35787932-ABE67C39-A3CC-41B1-9941-6E418DCDAA7D Q35842864-FCB5D4C7-9D36-4560-9075-C225708DFDD9 Q36186513-F62A5A66-96E7-4967-8F8E-4A5DDA9CD29C Q36228525-3B8B60CD-8E03-42E1-AD8F-1141DC41221D Q36407301-2BA2FBDC-6076-4F09-9F9B-69AB5E6C8C1F Q36599172-12FF8154-EDE6-4866-BAE2-593974390376 Q36612922-CD8AB371-874F-4112-8741-306BBC3A6C04

P2860

Brain atrophy in healthy aging is related to CSF levels of Aβ1-42.

http://www.wikidata.org/entity/Q34514638

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Brain atrophy in healthy aging is related to CSF levels of Aβ1-42.

@ast

Brain atrophy in healthy aging is related to CSF levels of Aβ1-42.

@en

Brain atrophy in healthy aging is related to CSF levels of Aβ1-42.

@nl

type

label

Brain atrophy in healthy aging is related to CSF levels of Aβ1-42.

@ast

Brain atrophy in healthy aging is related to CSF levels of Aβ1-42.

@en

Brain atrophy in healthy aging is related to CSF levels of Aβ1-42.

@nl

prefLabel

Brain atrophy in healthy aging is related to CSF levels of Aβ1-42.

@ast

Brain atrophy in healthy aging is related to CSF levels of Aβ1-42.

@en

Brain atrophy in healthy aging is related to CSF levels of Aβ1-42.

@nl

P1433

Q34514638-D96C8D09-E9A8-45B8-B51D-84191EECFB42

P1476

Q34514638-CB5ED09B-2883-49A9-9163-0EB8AB22A55C

P2093

Q34514638-0A29E780-6A37-44C3-BF8D-75428ACA087D

Q34514638-4E056660-7616-4012-9A80-61758DFDDC2D

Q34514638-C0A52AB3-53BF-4B04-8762-76E34F79E65B

P2860

Q34514638-041E0B9B-1813-4871-B8A6-9C58EBF7567B

Q34514638-042DB816-A547-4DDC-BD14-5FF1753996A9

Q34514638-046DA733-20FA-4496-8D83-789882EBBB95

Q34514638-0C0A419A-90C3-4AA4-88F6-A9BBF2CA1160

Q34514638-13276473-89F6-4549-9163-1FAAEDE27A09

Q34514638-1394CD47-A777-4370-832C-DC06AA17FF72

Q34514638-1434A167-FE08-49F2-B885-CFBDAA8C0E10

Q34514638-1C460382-CB93-451B-96D8-27ED626CE61C

Q34514638-1D6C073B-BF2B-4683-8A28-1025BC474C45

Q34514638-22F9518E-80B2-4447-8952-7F1EC28D0FC9

P304

Q34514638-FFF9183A-1A26-4FE1-AA46-97DA61FDA78C

P31

Q34514638-4D031ADD-E2DF-4CE8-9E64-A002DB958767

P356

Q34514638-F61045D9-D5AC-42D5-8879-59E44F725F52

P433

Q34514638-07159EAE-52DF-43B5-814C-911CE7CEE40B

P478

Q34514638-A5145909-4D80-4262-A051-14FC50CD8D17

P50

Q34514638-2DCD71A3-5DD6-47F2-B97D-6FBDCED84155

Q34514638-4DB8BCA0-D4F4-4376-A401-F2D4F615562B

Q34514638-4EC66019-A5A2-444A-BBB1-7D7BD5EF374E

Q34514638-7FA6DCF8-3B91-4B82-9ABB-8F22465466E5

Q34514638-A23C10E2-7FC6-49F1-9F8D-406DD7450A11

Q34514638-D38F68A1-E054-4C07-9FAC-D00D212AD58F

Q34514638-FD525140-BEC5-450F-8D06-85E2E8D014E7

P577

Q34514638-4343B750-91AE-4883-91B3-8C81856EAEE3

P5875

Q34514638-8CCE9250-6B53-4C0D-9C67-AA9B09CB7407

P698

Q34514638-CE0CEF87-6FDA-4770-AB8F-477BBECB3921

P932

Q34514638-FA3CDC8A-BE7F-4B0A-9B60-2F29958663CB

P356

P1433

Cerebral Cortex

P1476

Brain atrophy in healthy aging is related to CSF levels of Aβ1-42.

@en

P2093

Donald J Hagler

http://www.w3.org/2001/XMLSchema#string

James B Brewer

http://www.w3.org/2001/XMLSchema#string

Linda K McEvoy

http://www.w3.org/2001/XMLSchema#string

P2860

Synapse Formation and Function Is Modulated by the Amyloid Precursor Protein

APP binds DR6 to trigger axon pruning and neuron death via distinct caspases

Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory

“Mini-mental state”

Neuropathological stageing of Alzheimer-related changes

Cortical Surface-Based Analysis

Deformable templates using large deformation kinematics

Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain

Cortical surface-based analysis. II: Inflation, flattening, and a surface-based coordinate system

An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest

P304

2069-2079

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/CERCOR/BHP279

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P50

Kristine Beate Walhovd

Christine Fennema-Notestine

Alzheimer's Disease Neuroimaging Initiative

Dominic Holland

P577

2010-01-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

40850205

http://www.w3.org/2001/XMLSchema#string

P698

20051356

http://www.w3.org/2001/XMLSchema#string

P932

3025722

http://www.w3.org/2001/XMLSchema#string